vs
CSW INDUSTRIALS, INC.（CSW）与Oncology Institute, Inc.（TOI）财务数据对比。点击上方公司名可切换其他公司
CSW INDUSTRIALS, INC.的季度营收约是Oncology Institute, Inc.的1.6倍（$233.0M vs $142.0M），CSW INDUSTRIALS, INC.净利率更高（4.4% vs -5.3%，领先9.7%），Oncology Institute, Inc.同比增速更快（41.6% vs 20.3%），CSW INDUSTRIALS, INC.自由现金流更多（$22.7M vs $2.2M），过去两年Oncology Institute, Inc.的营收复合增速更高（22.5% vs 5.1%）
肿瘤研究所股份有限公司是一家专注于肿瘤诊疗领域的专业医疗企业，提供循证抗癌治疗方案、临床试验参与通道及配套支持护理服务，主要面向美国境内各类癌症患者，协同医疗从业者优化诊疗效果。
CSW vs TOI — 直观对比
营收规模更大
CSW
是对方的1.6倍
$142.0M
营收增速更快
TOI
高出21.3%
20.3%
净利率更高
CSW
高出9.7%
-5.3%
自由现金流更多
CSW
多$20.5M
$2.2M
两年增速更快
TOI
近两年复合增速
5.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $233.0M | $142.0M |
| 净利润 | $10.3M | $-7.5M |
| 毛利率 | 39.7% | — |
| 营业利润率 | 7.4% | -4.9% |
| 净利率 | 4.4% | -5.3% |
| 营收同比 | 20.3% | 41.6% |
| 净利润同比 | -61.9% | 43.0% |
| 每股收益（稀释后） | $0.62 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSWTOI
| Q4 25 | $233.0M | $142.0M | ||
| Q3 25 | $277.0M | $136.6M | ||
| Q2 25 | $263.6M | $119.8M | ||
| Q1 25 | $230.5M | $104.4M | ||
| Q4 24 | $193.6M | $100.3M | ||
| Q3 24 | $227.9M | $99.9M | ||
| Q2 24 | $226.2M | $98.6M | ||
| Q1 24 | $210.9M | $94.7M |
净利润CSWTOI
| Q4 25 | $10.3M | $-7.5M | ||
| Q3 25 | $40.7M | $-16.5M | ||
| Q2 25 | $40.9M | $-17.0M | ||
| Q1 25 | $35.1M | $-19.6M | ||
| Q4 24 | $26.9M | $-13.2M | ||
| Q3 24 | $36.1M | $-16.1M | ||
| Q2 24 | $38.6M | $-15.5M | ||
| Q1 24 | $31.8M | $-19.9M |
毛利率CSWTOI
| Q4 25 | 39.7% | — | ||
| Q3 25 | 43.0% | — | ||
| Q2 25 | 43.8% | — | ||
| Q1 25 | 44.2% | — | ||
| Q4 24 | 41.4% | — | ||
| Q3 24 | 45.6% | — | ||
| Q2 24 | 47.5% | — | ||
| Q1 24 | 44.4% | — |
营业利润率CSWTOI
| Q4 25 | 7.4% | -4.9% | ||
| Q3 25 | 20.5% | -5.9% | ||
| Q2 25 | 20.8% | -9.4% | ||
| Q1 25 | 19.5% | -9.5% | ||
| Q4 24 | 15.3% | -11.9% | ||
| Q3 24 | 22.6% | -13.9% | ||
| Q2 24 | 24.3% | -16.6% | ||
| Q1 24 | 21.0% | -19.0% |
净利率CSWTOI
| Q4 25 | 4.4% | -5.3% | ||
| Q3 25 | 14.7% | -12.1% | ||
| Q2 25 | 15.5% | -14.2% | ||
| Q1 25 | 15.2% | -18.8% | ||
| Q4 24 | 13.9% | -13.1% | ||
| Q3 24 | 15.8% | -16.1% | ||
| Q2 24 | 17.1% | -15.7% | ||
| Q1 24 | 15.1% | -21.0% |
每股收益（稀释后）CSWTOI
| Q4 25 | $0.62 | $-0.04 | ||
| Q3 25 | $2.41 | $-0.14 | ||
| Q2 25 | $2.43 | $-0.15 | ||
| Q1 25 | $2.05 | $-0.21 | ||
| Q4 24 | $1.60 | $-0.14 | ||
| Q3 24 | $2.26 | $-0.18 | ||
| Q2 24 | $2.47 | $-0.17 | ||
| Q1 24 | $2.03 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $40.2M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | $-15.7M |
| 总资产 | $2.3B | $164.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CSWTOI
| Q4 25 | $40.2M | — | ||
| Q3 25 | $31.5M | — | ||
| Q2 25 | $38.0M | — | ||
| Q1 25 | $225.8M | — | ||
| Q4 24 | $213.8M | — | ||
| Q3 24 | $273.2M | — | ||
| Q2 24 | $18.9M | $9.9M | ||
| Q1 24 | $22.2M | $29.8M |
总债务CSWTOI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $800.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $166.0M | — |
股东权益CSWTOI
| Q4 25 | $1.1B | $-15.7M | ||
| Q3 25 | $1.1B | $-12.3M | ||
| Q2 25 | $1.1B | $-9.0M | ||
| Q1 25 | $1.1B | $5.1M | ||
| Q4 24 | $1.0B | $3.6M | ||
| Q3 24 | $1.0B | $15.5M | ||
| Q2 24 | $650.2M | $29.2M | ||
| Q1 24 | $615.7M | $41.3M |
总资产CSWTOI
| Q4 25 | $2.3B | $164.7M | ||
| Q3 25 | $1.5B | $163.6M | ||
| Q2 25 | $1.5B | $159.8M | ||
| Q1 25 | $1.4B | $164.0M | ||
| Q4 24 | $1.4B | $172.7M | ||
| Q3 24 | $1.4B | $179.2M | ||
| Q2 24 | $1.1B | $179.6M | ||
| Q1 24 | $1.0B | $204.5M |
负债/权益比CSWTOI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.27× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $22.7M | $2.2M |
| 自由现金流率自由现金流/营收 | 9.8% | 1.5% |
| 资本支出强度资本支出/营收 | 2.6% | 0.7% |
| 现金转化率经营现金流/净利润 | 2.81× | — |
| 过去12个月自由现金流最近4个季度 | $162.0M | $-27.8M |
8季度趋势，按日历期对齐
经营现金流CSWTOI
| Q4 25 | $28.9M | $3.2M | ||
| Q3 25 | $61.8M | $-12.6M | ||
| Q2 25 | $60.6M | $-10.2M | ||
| Q1 25 | $27.3M | $-5.0M | ||
| Q4 24 | $11.6M | $4.2M | ||
| Q3 24 | $66.8M | $819.0K | ||
| Q2 24 | $62.7M | $-15.7M | ||
| Q1 24 | $22.4M | $-15.9M |
自由现金流CSWTOI
| Q4 25 | $22.7M | $2.2M | ||
| Q3 25 | $58.7M | $-13.2M | ||
| Q2 25 | $57.7M | $-11.4M | ||
| Q1 25 | $22.8M | $-5.3M | ||
| Q4 24 | $8.5M | $2.4M | ||
| Q3 24 | $61.3M | $417.0K | ||
| Q2 24 | $59.6M | $-17.5M | ||
| Q1 24 | $17.5M | $-16.5M |
自由现金流率CSWTOI
| Q4 25 | 9.8% | 1.5% | ||
| Q3 25 | 21.2% | -9.7% | ||
| Q2 25 | 21.9% | -9.5% | ||
| Q1 25 | 9.9% | -5.1% | ||
| Q4 24 | 4.4% | 2.4% | ||
| Q3 24 | 26.9% | 0.4% | ||
| Q2 24 | 26.3% | -17.7% | ||
| Q1 24 | 8.3% | -17.4% |
资本支出强度CSWTOI
| Q4 25 | 2.6% | 0.7% | ||
| Q3 25 | 1.1% | 0.4% | ||
| Q2 25 | 1.1% | 1.0% | ||
| Q1 25 | 2.0% | 0.3% | ||
| Q4 24 | 1.6% | 1.8% | ||
| Q3 24 | 2.4% | 0.4% | ||
| Q2 24 | 1.4% | 1.9% | ||
| Q1 24 | 2.3% | 0.6% |
现金转化率CSWTOI
| Q4 25 | 2.81× | — | ||
| Q3 25 | 1.52× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 0.71× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSW
| Contractor Solutions Segment | $166.3M | 71% |
| Specialized Reliability Solutions Segment | $38.2M | 16% |
| Engineered Building Solutions Segment | $28.5M | 12% |
TOI
| Other | $82.1M | 58% |
| Fee For Service | $36.3M | 26% |
| Capitated Revenue | $23.6M | 17% |
